- Home
- PCRX vs EMO Comparison
PCRX vs EMO Comparison
Compare PCRX & EMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- EMO
- Stock Information
- Founded
- PCRX 2006
- EMO 2011
- Country
- PCRX United States
- EMO United States
- Employees
- PCRX N/A
- EMO N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- EMO Investment Managers
- Sector
- PCRX Health Care
- EMO Finance
- Exchange
- PCRX Nasdaq
- EMO Nasdaq
- Market Cap
- PCRX 604.7M
- EMO 599.1M
- IPO Year
- PCRX 2011
- EMO N/A
- Fundamental
- Price
- PCRX $22.36
- EMO $50.42
- Analyst Decision
- PCRX Buy
- EMO
- Analyst Count
- PCRX 10
- EMO 0
- Target Price
- PCRX $27.60
- EMO N/A
- AVG Volume (30 Days)
- PCRX 798.1K
- EMO 27.1K
- Earning Date
- PCRX 02-27-2025
- EMO 01-01-0001
- Dividend Yield
- PCRX N/A
- EMO 6.70%
- EPS Growth
- PCRX N/A
- EMO N/A
- EPS
- PCRX N/A
- EMO N/A
- Revenue
- PCRX $694,957,000.00
- EMO N/A
- Revenue This Year
- PCRX $4.83
- EMO N/A
- Revenue Next Year
- PCRX $2.16
- EMO N/A
- P/E Ratio
- PCRX N/A
- EMO N/A
- Revenue Growth
- PCRX 4.40
- EMO N/A
- 52 Week Low
- PCRX $11.16
- EMO $26.42
- 52 Week High
- PCRX $34.01
- EMO $40.17
- Technical
- Relative Strength Index (RSI)
- PCRX 70.92
- EMO 73.13
- Support Level
- PCRX $18.18
- EMO $49.02
- Resistance Level
- PCRX $22.36
- EMO $47.92
- Average True Range (ATR)
- PCRX 1.13
- EMO 0.94
- MACD
- PCRX 0.30
- EMO 0.48
- Stochastic Oscillator
- PCRX 93.11
- EMO 94.34
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About EMO ClearBridge Energy Midstream Opportunity Fund Inc.
ClearBridge Energy Midstream Opportunity Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide long-term investors with a high level of total return with an emphasis on cash distributions.